LSA
BIIB icon

L & S Advisors’s Biogen BIIB Stock Holding History

L & S Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,905
Closed -$2.38M – 85
2015
Q2 		$2.38M Sell
5,905
-26
-0.4% -$10.4K 0.61% 62
2015
Q1 		$2.5M Buy
+5,931
New +$2.34M 0.66% 52
2013
Q4 		– Sell
-21,220
Closed -$5.11M – 88
2013
Q3 		$5.11M Buy
21,220
+6,046
+40% +$1.35M 2.07% 14
2013
Q2 		$3.27M Buy
+15,174
New +$3.24M 1.59% 29

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

L & S Advisors's BIIB Position: Q3 2015 in Review

L & S Advisors sold out of Biogen (BIIB) in Q3 2015, closing a stake of 5,905 shares — an estimated $2.38M sold.

L & S Advisors first reported a position in BIIB in Q2 2013 and held it in 4 quarters. The position peaked at $5.11M in Q3 2013. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • L & S Advisors reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • L & S Advisors sold 5,905 Biogen shares in Q3 2015, an estimated $2.38M.
  • L & S Advisors first reported a position in Biogen in Q2 2013 and held it in 4 quarters.
  • L & S Advisors's Biogen position peaked at $5.11M in Q3 2013.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on L & S Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.